Français
ItalianoBond AbbVie Inc. 0.691% ( US00287YBK47 ) in USD
| Issuer | AbbVie Inc. |
| Market price | 100 % ▼ |
| Country |  United States
|
| ISIN code |
 US00287YBK47 ( in USD )
|
| Interest rate | 0.691% per year ( payment 2 times a year) |
| Maturity | 21/09/2050 - Bond has expired |
|
Prospectus brochure in PDF format is unavailable at this time We will provide it as soon as possible |
|
| Minimal amount | 2 000 USD |
| Total amount | / |
| Cusip | 00287YBK4 |
| Standard & Poor's ( S&P ) rating | BBB+ ( Lower medium grade - Investment-grade ) |
| Moody's rating | Baa2 ( Lower medium grade - Investment-grade ) |
| Detailed description |
AbbVie is a research-based biopharmaceutical company focused on developing and marketing innovative therapies in several key therapeutic areas including immunology, oncology, neuroscience, and ophthalmology. This financial report details the bond, ISIN US00287YBK47 and CUSIP 00287YBK4, issued in the United States by AbbVie, a global biopharmaceutical company renowned for its research-based approach to developing advanced therapies across immunology, oncology, neuroscience, and virology, which was denominated in USD, carried an interest rate of 0.691%, featured a minimum purchase size of 2000 units, paid interest semi-annually, matured on September 21, 2050, and has since been fully redeemed at its 100% market price, having received a BBB+ rating from Standard & Poor's and a Baa2 rating from Moody's. |